日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers

异染色质的完整性是淋巴瘤和其他人类癌症治疗中的一个软肋。

Najia, Mohamad Ali; Jha, Deepak K; Zhang, Cheng; Laurent, Benoit; Kubaczka, Caroline; Markel, Arianna; Li, Christopher; Morris, Vivian; Tompkins, Allison; Hensch, Luca; Qin, Yue; Chapuy, Bjoern; Huang, Yu-Chung; Morse, Michael; Marunde, Matthew R; Vaidya, Anup; Gillespie, Zachary B; Howard, Sarah A; North, Trista E; Dominguez, Daniel; Keogh, Michael-Christopher; Schlaeger, Thorsten M; Shi, Yang; Li, Hu; Shipp, Margaret M; Blainey, Paul C; Daley, George Q

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Tislelizumab联合zanubrutinib治疗Richter转化:RT1 II期试验

Al-Sawaf, Othman; Ligtvoet, Rudy; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Tausch, Eugen; Schneider, Christof; Boettcher, Sebastian; Mikusko, Martin; Ritgen, Matthias; Schetelig, Johannes; von Tresckow, Julia; Vehling-Kaiser, Ursula; Gaska, Tobias; Wendtner, Clemens Martin; Chapuy, Bjoern; Fischer, Kirsten; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Staber, Philipp; Niemann, Carsten; Hallek, Michael; Eichhorst, Barbara

A Portfolio Analysis of Nutritional Biomarkers in NIH- and NHLBI-funded Research, 2008–2020

2008-2020年美国国立卫生研究院和国家心肺血液研究所资助的研究中营养生物标志物的项目组合分析

Chapuy, Bjoern; McKeown, Michael R; Lin, Charles Y; Monti, Stefano; Roemer, Margaretha G M; Qi, Jun; Rahl, Peter B; Sun, Heather H; Yeda, Kelly T; Doench, John G; Reichert, Elaine; Kung, Andrew L; Rodig, Scott J; Young, Richard A; Shipp, Margaret A; Bradner, James E; Pratt, Charlotte; Feudo, Sam

The EHA Research Roadmap: Malignant Lymphoid Diseases

欧洲血液学协会研究路线图:恶性淋巴系统疾病

Dreyling, Martin; André, Marc; Gökbuget, Nicola; Tilly, Hervé; Jerkeman, Mats; Gribben, John; Ferreri, Andrés; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher; Maria Ribera, José; Zweegman, Sonja; Aurer, Igor; Bödör, Csaba; Burkhardt, Birgit; Buske, Christian; Dollores Caballero, Maria; Campo, Elias; Chapuy, Bjoern; Davies, Andrew; de Leval, Laurence; Doorduijn, Jeanette; Federico, Massimo; Gaulard, Philippe; Gay, Francesca; Ghia, Paolo; Grønbæk, Kirsten; Goldschmidt, Hartmut; Kersten, Marie-Jose; Kiesewetter, Barbara; Landman-Parker, Judith; Le Gouill, Steven; Lenz, Georg; Leppä, Sirpa; Lopez-Guillermo, Armando; Macintyre, Elizabeth; Mantega, Maria Victoria Mateos; Moreau, Philippe; Moreno, Carol; Nadel, Bertrand; Okosun, Jessica; Owen, Roger; Pospisilova, Sarka; Pott, Christiane; Robak, Tadeusz; Spina, Michelle; Stamatopoulos, Kostas; Stary, Jan; Tarte, Karin; Tedeschi, Allessandra; Thieblemont, Catherine; Trappe, Ralf Ulrich; Trümper, Lorenz H; Salles, Gilles

Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

低血清白蛋白是老年侵袭性B细胞淋巴瘤患者的独立危险因素:来自德国高级别非霍奇金淋巴瘤研究组前瞻性试验的结果

Hohloch, Karin; Ziepert, Marita; Truemper, Lorenz; Buske, Christian; Held, Gerhard; Poeschel, Viola; Chapuy, Bjoern; Altmann, Bettina

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

PMBL的基因组分析揭示了对PD-1阻断剂敏感性的新驱动因素和机制

Chapuy, Bjoern; Stewart, Chip; Dunford, Andrew J; Kim, Jaegil; Wienand, Kirsty; Kamburov, Atanas; Griffin, Gabriel K; Chen, Pei-Hsuan; Lako, Ana; Redd, Robert A; Cote, Claire M; Ducar, Matthew D; Thorner, Aaron R; Rodig, Scott J; Getz, Gad; Shipp, Margaret A

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

弥漫性大B细胞淋巴瘤的分子亚型与不同的发病机制和预后相关。

Chapuy, Bjoern; Stewart, Chip; Dunford, Andrew J; Kim, Jaegil; Kamburov, Atanas; Redd, Robert A; Lawrence, Mike S; Roemer, Margaretha G M; Li, Amy J; Ziepert, Marita; Staiger, Annette M; Wala, Jeremiah A; Ducar, Matthew D; Leshchiner, Ignaty; Rheinbay, Ester; Taylor-Weiner, Amaro; Coughlin, Caroline A; Hess, Julian M; Pedamallu, Chandra S; Livitz, Dimitri; Rosebrock, Daniel; Rosenberg, Mara; Tracy, Adam A; Horn, Heike; van Hummelen, Paul; Feldman, Andrew L; Link, Brian K; Novak, Anne J; Cerhan, James R; Habermann, Thomas M; Siebert, Reiner; Rosenwald, Andreas; Thorner, Aaron R; Meyerson, Matthew L; Golub, Todd R; Beroukhim, Rameen; Wulf, Gerald G; Ott, German; Rodig, Scott J; Monti, Stefano; Neuberg, Donna S; Loeffler, Markus; Pfreundschuh, Michael; Trümper, Lorenz; Getz, Gad; Shipp, Margaret A

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

PD-L1和PD-L2基因改变定义了经典型霍奇金淋巴瘤并预测了预后

Roemer, Margaretha G M; Advani, Ranjana H; Ligon, Azra H; Natkunam, Yasodha; Redd, Robert A; Homer, Heather; Connelly, Courtney F; Sun, Heather H; Daadi, Sarah E; Freeman, Gordon J; Armand, Philippe; Chapuy, Bjoern; de Jong, Daphne; Hoppe, Richard T; Neuberg, Donna S; Rodig, Scott J; Shipp, Margaret A

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

纳武利尤单抗治疗复发或难治性血液系统恶性肿瘤患者:一项 Ib 期研究的初步结果

Lesokhin, Alexander M; Ansell, Stephen M; Armand, Philippe; Scott, Emma C; Halwani, Ahmad; Gutierrez, Martin; Millenson, Michael M; Cohen, Adam D; Schuster, Stephen J; Lebovic, Daniel; Dhodapkar, Madhav; Avigan, David; Chapuy, Bjoern; Ligon, Azra H; Freeman, Gordon J; Rodig, Scott J; Cattry, Deepika; Zhu, Lili; Grosso, Joseph F; Bradley Garelik, M Brigid; Shipp, Margaret A; Borrello, Ivan; Timmerman, John

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

β2M/MHC I类分子表达降低的经典型霍奇金淋巴瘤与较差的预后相关,且与9p24.1状态无关。

Roemer, Margaretha G M; Advani, Ranjana H; Redd, Robert A; Pinkus, Geraldine S; Natkunam, Yasodha; Ligon, Azra H; Connelly, Courtney F; Pak, Christine J; Carey, Christopher D; Daadi, Sarah E; Chapuy, Bjoern; de Jong, Daphne; Hoppe, Richard T; Neuberg, Donna S; Shipp, Margaret A; Rodig, Scott J